(Q33903316)

29 July 2017

title

Long-term efficacy and safety of modafinil (PROVIGIL((R))) for the treatment of excessive daytime sleepiness associated with narcolepsy (English)

1 reference

excessive daytime sleepiness

29 July 2017

0 references

1 reference

1 reference

inferred from title

author

Christian Guilleminault

series ordinal

4

object named as

Guilleminault C

1 reference

29 July 2017

Mitler MM

1

1 reference

29 July 2017

Harsh J

series ordinal

2

1 reference

29 July 2017

Hirshkowitz M

series ordinal

3

1 reference

29 July 2017

publication date

1 July 2000

1 reference

29 July 2017

number of pages

13

1 reference

inferred from page(s)

published in

Sleep Medicine

1 reference

29 July 2017

volume

1

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

231-243

1 reference

Epidemiology of narcolepsy.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900031-9

7 January 2021

Familial patterns of narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900031-9

7 January 2021

DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900031-9

7 January 2021

Life effects of narcolepsy in 180 patients from North America, Asia and Europe compared to matched controls.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900031-9

7 January 2021

Narcolepsy-cataplexy. II. Psychosocial consequences and associated psychopathology.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900031-9

7 January 2021

Narcolepsy. Signs, symptoms, differential diagnosis, and management.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900031-9

7 January 2021

Evaluation of treatment with stimulants in narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900031-9

7 January 2021

Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900031-9

7 January 2021

Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900031-9

7 January 2021

Maintenance of wakefulness test: a polysomnographic technique for evaluation treatment efficacy in patients with excessive somnolence

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900031-9

7 January 2021

A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900031-9

7 January 2021

The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900031-9

7 January 2021

The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900031-9

7 January 2021

Epworth Sleepiness Scale outcome in 616 Brazilian medical students

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900031-9

7 January 2021

Correlates of daytime sleepiness in 4578 elderly persons: the Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900031-9

7 January 2021

Sleepiness and driving: the experience of heavy goods vehicle drivers in the UK

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900031-9

7 January 2021

Daytime sleepiness and sleep habits of Australian workers.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900031-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900031-9

7 January 2021

Quality of life assessment among migraine patients treated with sumatriptan

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900031-9

7 January 2021

10.1016/S1389-9457(00)00031-9

Identifiers

DOI

1 reference

29 July 2017

1 reference